Europe’s CHMP top scientific committee gave a positive opinion for approval to cladribine, with the proposed trade name Mavenclad, for relapsing forms of MS with high disease activity.

Merck KGaA’s Mavenclad (cladribine) tablets have been recommended by the National Institute for Health and Care Excellence (NICE) to treat a broader group of multiple sclerosis (MS) patients. The ...

Credit: MPE “If you look at the distribution of the galaxy clusters in the sky in a spherical shell with a distance of 416 to 826 million light-years, you immediately notice a huge structure that ...

Investopedia / Yurle Villegas An organizational chart, or org chart, graphically represents an organization's structure by detailing the roles, responsibilities, and relationships between ...

The second deal is with German pharma company Merck for its multiple sclerosis drug Mavenclad (cladribine ... to provide the pricing and access structure for most medicines.

She has 15+ years of experience as a financial writer and technical analyst. A firm's capital structure is a mix of borrowed money and investor funding that it uses to fund itself. When Meta ...